Okada M, Shindo T, Fujino K, Maeda T, Ito N, Takahashi A, Hotta H, Kunishima Y, Matsukawa M, Takayanagi A, Wanifuchi A, Nofuji S, Kato R, Fukuta F, Hashimoto K, Kobayashi K, Tanaka T, Masumori N: Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy. Support Care Cancer. 31(10):607, 2023
Tabata H, Tanaka T, Shindo T, Hashimoto K, Kobayashi K, Masumori N: Urethrectomy via parapenile incision to complete robot-assisted radical cystectomy in a spine position for male patients. Int J Urol. 30(10):936-938, 2023
Kato T, Wang C, Masumori N, Yamasaki T, Matsumoto H, Baba M, Ito K, Kimura T, Kitamura H, Takahashi M, Hongo F, Hasine K, Eto M, Ikeda JI, Nonomura N, Shinohara N: T1a renal cell carcinoma with metastasis: Japanese society of renal cancer retrospective multi-institute results.Anticancer Res. 43(9):4061-4065, 2023
Kadono Y, Konaka H, Nohara T, Izumi K, Anai S, Fujimoto K, Koguchi T, Ishibashi K, Kawai N, Nakane K, Iba A, Masumori N, Takahara S and Mizokami A: Efficacy and safety of firstline cytokines versus sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE Study): A phase III, randomized,sequential open-label study. Cancers.15(10):2745, 2023
Senda M, Hashimoto K, Shindo T, Kobayashi K, Tanaka T, Masumori N: Durable response to pembrolizumab in microsatellite instability-high advanced adrenocortical carcinoma. IJU CaseRep. 6(6):382-385, 2023
Abe J, Hashimoto K, Shindo T, Nakayama S, Ogasawara T, Kyoda Y, Kobayashi K, Tanaka T, Takada K, Sakurai A, Masumori N: Case of hereditary leiomyomatosis and renal cell cancer without cutaneous leiomyomas harboring a heterozygous germline mutation in the fumarate hydratase gene. Ann Clin Case Rep. 8(1):2456, 2023
Sato S, Tanaka T, Maehana T, Hashimoto K, Kobayashi K, Masumori N: Comparison of incidence of acute kidney injury after robot-assisted radical prostatectomy with that after open retropubic and extraperitoneal laparoscopic radical prostatectomies in patients with prostate cancer. Curr Urol. 18(2):139-143, 2023
Kyoda Y, Hashimoto K, Takahashi A, Maehana T, Tachikawa K, Muranaka T, Kato S, Kurisu T, Fukuta F, Kirisawa T, Okada M, Kobayashi K, Tanaka T, Hinotsu S, Masumori N: Which characteristics are associated with changes in medication status for lower urinary tract symptoms among patients with prostate cancer receiving external beam radiotherapy? Curr Urol. 18(2):122-127, 2023
Tsuzuki T, Ohe C, Osawa T, Yasuda Y, Tanaka T, Anai S, Kimura G, Yamana K, Hatakeyama S, Yoshimoto T, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H: Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study. Pathology. 55(1): 31-39, 2023
Tohi Y, Ishikawa R, Kato T, Miyakawa J, Matsumoto R, Mori K, Mitsuzuka K, Inokuchi J, Matsumura M, Shiga K, Naito H, Kohjimoto Y, Kawamura N, Inoue M, Kinoshita H, Hashimoto K, Goto K, Haba R, Kakehi Y, Sugimoto M: Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIASJAPAN study.. Int J Clin Oncol. 28(2):299-305, 2023
Terada N, Sawada A, Kawanishi H, Fujimoto T, Magaribuchi T, Chihara I, Hashimoto K, Sakurai T, Shimizu Y, Uegaki M, Nakashima M, Narita S, Kubota M, Yamada Y, Tohi Y, Okabe K, Yatsuda J, Kamoto T: The efficacy of sequential therapy with docetaxel and cabazitaxel for castration resistant prostate cancer: A retrospective multi-institutional study in Japan. Int J Urol. 30(2):227-234, 2023
Tanaka T, Yamasaki K, Nofuji S, Maehana T, Shindo T, Kyoda Y, Hashimoto K, Kobayashi K, Masumori N: Development and preliminary evaluation of a novel procedure for creation of an ileal conduit stoma aimed at preventing parastomal hernia. 2023 The 2nd Annual meeting of KUOS-EAUOS, 2023, September15-16, Incheon, Korea
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N: Optimal management of first-line chemotherapy for advanced urothelial carcinoma in chemotherapy and immune checkpoint inhibitor sequential therapy era. 2023 The 2nd Annual meeting of KUOS-EAUOS, 2023, September15-16, Incheon Korea
Hashimoto K: Current status and future perspectives on therapies for metastatic and nonmetastatic CRPC. 第110回日本泌尿器科学会総会、2023年4月20-23日、神戸
Shindo T: Clinical significance of maintenance avelumab therapy for metastatic urothelial carcinoma. 第110回日本泌尿器科学会総会、2023年4月20-23日、神戸
Shindo T, Hashimoto K, Kurisu T, Hotta H, Kato R, Maeda T, Fukuta F, Ito N, Kunishima Y, Matsukawa M, Kobayashi K, Tanaka T, Masumori N: Serum testosterone as a biomarker for patients selection for flutamide use in metastatic castration resistant prostate cancer. 第110回日本泌尿器科学会総会、2023年4月20-23日、神戸
Nakayama S, Hashimoto K, Abe J, Ogasawara T, Okabe Ko, Shindo T, Kobayashi K, Tanaka T, Takada K, Masumori N: The outcome of genetic testing for patients with castration-resistant prostate cancer in our institute. 第110回日本泌尿器科学会総会、2023年4月20-23日、神戸
Tanaka T, Maehana T, Shindo T, Kyoda Y, Hashimoto K, Kobayashi K, Masumori N: Development and preliminary evaluation of a novel procedure for creation of an ileal conduit stoma aimed at preventing parastomal hernia. 第61回日本癌治療学会学術集会、2023年10月19-21日、横浜
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N: Prognostic classification for advanced urothelial carcinoma patients in chemotherapy and immune checkpoint inhibitor therapy era. 第61回日本癌治療学会学術集会、2023年10月19-21日、横浜
Kyoda Y, Hashimoto K, Takahashi A, Maehana T, Tachikawa K, Muranaka T, Kato S, Kurisu T, Fukuta F, Kirisawa T, Okada M, Kobayashi K, Tanaka T, Hinotsu S, Masumori N: Which characteristics are associated with changes in medication status for lower urinary tract symptoms among patients with prostate cancer receiving external beam radiotherapy? Curr Urol.18(2):122-127, 2024
Wanifuchi A, Kyoda Y, Ogasawara T , Kobayashi K , Ito N, Shindo T, Takahashi A, Kunishima Y, Masumori N: Difference in symptom manifestation between postmenopausal and premenopausal women in acute uncomplicated cystitis: A multi-institutional pilot study. Curr Urol. 17(3):174-178, 2023
Kyoda Y, Ichihara K, Muranaka I, Sakai Y, Nakamura M, Shinkai N, Kozen N, Yorozuya W, Morooka D, Maruo K, Tachikawa K,Shibamori K, Nofuji1 S, Fujino K, Kato S, Yoshida T, Shindo T, Maehana T, Hashimoto K, Kobayashi K, Tanaka T, Masumori N: Efficacy of cognitive behavioral therapy using self-check sheet for patients with nocturia in real-world clinical practice. Low Urin Tract Symptoms. 15(6):225-230, 2023
太刀川公人、京田有樹、舛森直哉:論文解説 : Efficacy Of vibegron in Patients with overactive bladder : Multicenter prospective study of real-world clinical practice in Japan, SCCOP study 19-01、排尿障害プラクティス 31(1) :74-80, 2023
京田有樹、舛森直哉:OAB の治療 up to date BPH/OAB の治療 up to date ―薬物療法 , 手術―特集 過活動膀胱 up to date 2023、泌尿器外科 36(6):487-491, 2023
京田有樹、舛森直哉:PVP と PUL―他とは何が違うのかー、シンポジウム 5 Think different in BPH surgery、泌尿器外科 36(臨増):726, 2023
Shibamori K, Kyoda Y, Shinkai N, Maehana T, Shindo T, Nishida S, Hashimoto K, Kobayashi K, Tanaka T, Suzuki H, Masumori N: Maternal diet during gestation affect prostatic tissue component in SHR/Izm offspring. European Association of Urology Annual Congress 2023, March 10-13, Milan, Italy
Kyoda Y, Ichihara K, Muranaka I, Sakai Y, Nakamura M, Shinkai N, Kozen N, Yorozuya W,Morooka D, Maruo K, Tachikawa K, Shibamori K, Nofuji S, Fujino K, Kato S, Yoshida T, Shindo T, Maehana T, Hashimoto K, Kobayashi K, Tanaka T, Masumori N: Efficacy of cognitive behavioral therapy using self-check sheet against the patients with nocturia in real-world clinical practice. 第110回日本泌尿器科学会総会、2023年4月20-23日、神戸
Ichihara K: Algorithm of IC/BPS diagnosis and treatment in Japan. 2023 Taiwan Urological Association Annual Meeting, 2023年8月18-19日, Taiwan Taipei
Tabata H, Kyoda Y, Nofuji S, Kobayashi K, Tanaka T, Masumori N: Voiding with unclear urinary sensation is a risk factor for post micturition dribble. International Continence Society 2023, 2023年9月27-29日, Canada, Toronto
KyodaY, Tabata H, Shibamori K,Nofuji S, Hashimoto K, Kobayashi K, Tanaka T, Masumori N: The change of detrusor contractility at 2 years after transurethral resection of the prostate. The 17th Pan-PacificContinence Society Meeting, 2023年10月14-15日, Taiwan Takao
Nofuji S, Kyoda Y, Fukuta F, Okada M, Kato R, Takahashi A, Tachiki H, Miyao N, Hashimoto K, Kobayashi K, Tanaka T, Masumori N: Efficacy of dutasteride for patients with prostate volume of less than 30mL - a prospective multicenter study. The 39th KOREA-JAPAN Urological Congress, October 27-28, 2023, Tsukuba, Japan
Sato S, Toshiaki T, Maehana T, Hashimoto K, Kobayashi K, Masumori N: Comparison of incidence of acute kidney injury after robot-assisted radical prostatectomy with that after open retropubic and extraperitoneal laparoscopic radical prostatectomies in patients with prostate cancer. Curr Urol. 18(2):139-1432023
Kohei N, Tanaka T, Miyairi S, Tsuda H, Abe T, Su CA, Kish DD, Tanabe K, Valujskikh A, Min B, Fairchild RL: Failure of Costimulatory blockade-induced regulatory T cells to sustain long-term survival of high ischemic allografts. Transplantation 107(9):1935-1944, 2023